Homepage
Author:
Oak Street Communications
Posted Date:
April 9, 2026
DeepCyte Raises $1.5M to Bring Single-Cell AI Toxicology to Drug Development
Oak Street Communications
April 9, 2026
Ultima Genomics Announces UG200 Series Selected for Basecamp Research’s Groundbreaking Trillion Gene Atlas
Oak Street Communications
March 19, 2026
Minaris Launches AgentSCREEN Adventitious Virus Detection by NGS to Simplify Viral Safety Testing for Cell Banks and Cell-Based Samples
Oak Street Communications
March 4, 2026
Ultima Genomics and Hamilton Partner to Automate Sample Preparation and Amplification Workflows for the Ultima Family of Sequencing Systems to Enable Improved Lab Operations and Drive Sequencing at Scale
Oak Street Communications
February 25, 2026
Ultima Genomics Introduces the Next Generation of Sequencing at Scale with the Launch of the UG200™ Series and Next Generation Solaris 2.0 Workflows Delivering Higher Output, Better Performance and More Flexible Wafer Configurations
Oak Street Communications
February 23, 2026
Stellaromics Launches Pyxa™ at AGBT, the First Commercial Platform for 3D Spatial Multi-Omics in Intact Tissue
Oak Street Communications
February 19, 2026
Stellaromics Appoints Industry Veterans Stacie Weninger and Steve McPhail to Board of Directors
Oak Street Communications
February 12, 2026
Ultima Genomics Strengthens Oncology Leadership to Drive Clinical Growth
Oak Street Communications
February 11, 2026
Stellaromics Expands Pyxa™ 3D Spatial Transcriptomics Beta Program with Installation at Emory University School of Medicine
Oak Street Communications
January 28, 2026
Minaris Announces Viral Clearance Laboratory Upgrade at Philadelphia Campus
Oak Street Communications
January 28, 2026
